Welcome to Eureka model portfolios
Here's your guide to our offerings in growth, income, international and LICs.
The Greek tragedy's effect on yield
Greek debt negotiations could accelerate interest rate cuts in Australia.
At last… corporate bonds for everyone
XTBs are a unitised version of corporate bonds that allow retail investors into the market. They're not perfect, but very welcome.
New year, new limits for super
The start of a new financial year inevitably brings adjustments. Here's what you need to consider.
Going International with Gilead Sciences Inc.
Gilead Sciences Inc. (NASDAQ: GILD) is a large US biotech stock specialising in antiviral drugs to treat patients suffering from HIV, hepatitis C, influenza and other medical conditions. As the world's leading anti-viral company, Gilead holds strong market positions in some very lucrative markets. For investors the attraction of Gilead is its valuation, free cash-flow and potential growth opportunity.
Weaker iron ore prices to weigh on market
International markets appear to have found a level where they are happy to sit and wait on the next developments in the Greek debt crisis. Greece's failure to meet the deadline on its IMF payment looks to have been fully anticipated by markets. Barring unknowns, the next critical event for markets will be the outcome of Sunday's referendum.
Giving up on Azure
The clinical workflow company has issued another profit warning due to higher costs - but we have lost faith in the group.
Investing in IPOs: A Eureka guide
Before deciding to participate in an IPO it is essential that investors make three considerations.
NBN rolls out higher earnings for NetComm
The M2M products provider has beaten expectations with its earnings guidance for FY15.
Disney hits light speed
The media conglomerate is set to wow audiences and investors alike following recent initiatives.
Collected Wisdom
This week we look at IOOF Holdings, Slater & Gordon, Flight Centre, Seek and Bradken.
Flight to quality
Initial market reactions to weekend news on Greece have understandably involved a flight to quality. This morning's early market reaction has included selling Eurodollars and stock futures on the one hand and buying $US; Japanese yen and gold on the other.
Where SMSFs can turn for 'validation'
Trustees of self-managed super funds can build some investment confidence if they follow the simple rules of allocation and diversification.
Greece and US interest rates remain the key focus
Markets seem to be exactly where they were last Friday as far as Greece is concerned. The world is waiting on another set of "last ditch" meetings with a general expectation that crisis will be averted but concerned that there is some room for doubt. The bottom line as far as today's trading is concerned may be to leave both buyers and sellers cautious.